Right target, but missing the bulls-eye for Alzheimer's
Thursday, January 24, 2013 - 00:30
in Biology & Nature
For decades now, researchers have been trying, without success, to develop drugs that slow or prevent Alzheimer’s. Now research at suggests that while the protein they have been focusing on-- amyloid-beta -- is the right one, what’s needed is to direct a drug to a very specific location, which they’ve discovered, on that protein.